Hematopoietic Fas deficiency does not affect experimental atherosclerotic lesion formation despite inducing a proatherogenic state

American Journal of Pathology

Volumn 178, Issue 6, 2011, Pages 2931-2937

  De Claro, R Angelo ^a   Zhu, Xiaodong ^a   Tang, Jingjing ^a   Morgan Stevenson, Vicki ^b   Schwartz, Barbara R ^a   Iwata, Akiko ^b   Liles, W Conrad ^a   Raines, Elaine W ^a   Harlan, John M ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; FAS ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; BRACHIOCEPHALIC TRUNK; CHOLESTEROL DIET; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LYMPHOCYTE PROLIFERATION; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMATIC REVIEW; WILD TYPE;

EID: 79959376213     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.02.011     Document Type: Article

References (42)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ: Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367:1747-1757 (Pubitemid 43767064)
2. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126
3. Libby P: Inflammation in atherosclerosis. Nature 2002, 420:868-874 (Pubitemid 36019640)
4. Nagata S, Golstein P: The Fas death factor. Science 1995, 267:1449-1456
5. Cai W, Devaux B, Schaper W, Schaper J: The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions. Atherosclerosis 1997, 131:177-186 (Pubitemid 27232439)
6. Park DR, Thomsen AR, Frevert CW, Pham U, Skerrett SJ, Kiener PA, Liles WC: Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J Immunol 2003, 170:6209-6216 (Pubitemid 36682605)
7. Perlman H, Pagliari LJ, Georganas C, Mano T, Walsh K, Pope RM: FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis. J Exp Med 1999, 190:1679-1688 (Pubitemid 30002349)
8. Fukui M, Imamura R, Umemura M, Kawabe T, Suda T: Pathogenassociated molecular patterns sensitize macrophages to Fas ligandinduced apoptosis and IL-1 beta release. J Immunol 2003, 171:1868-1874 (Pubitemid 36966469)
9. Wajant H, Pfizenmaier K, Scheurich P: Non-apoptotic Fas signaling. Cytokine Growth Factor Rev 2003, 14:53-66 (Pubitemid 36098431)
10. Park SM, Schickel R, Peter ME: Nonapoptotic functions of FADDbinding death receptors and their signaling molecules. Curr Opin Cell Biol 2005, 17:610-616 (Pubitemid 41540410)
11. Altemeier WA, Zhu X, Berrington WR, Harlan JM, Liles WC: Fas (CD95) induces macrophage proinflammatory chemokine production via a MyD88-dependent, caspase-independent pathway. J Leukoc Biol 2007, 82:721-728 (Pubitemid 47367164)
12. Adachi M, Suematsu S, Kondo T, Ogasawara J, Tanaka T, Yoshida N, Nagata S: Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat Genet 1995, 11:294-300
13. Cohen PL, Eisenberg RA: Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 1991, 9:243-269
14. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992, 356:314-317
15. Feng X, Li H, Rumbin AA, Wang X, La Cava A, Brechtelsbauer K, Castellani LW, Witztum JL, Lusis AJ, Tsao BP: ApoE-/-Fas-/- C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia. J Lipid Res 2007, 48:794-805 (Pubitemid 46557884)
16. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Cote R, Grover SA, Fortin PR, Clarke AE, Senécal JL: Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001, 44:2331-2337 (Pubitemid 32977500)
17. Adachi M, Suematsu S, Suda T, Watanabe D, Fukuyama H, Ogasawara J, Tanaka T, Yoshida N, Nagata S: Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc Natl Acad Sci USA 1996, 93:2131-2136 (Pubitemid 26079893)
18. Hartvigsen K, Binder CJ, Hansen LF, Rafia A, Juliano J, Horkko S, Steinberg D, Palinski W, Witztum JL, Li AC: A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome. Arterioscler Thromb Vasc Biol 2007, 27: 878-885 (Pubitemid 46606720)
19. Gough PJ, Gomez IG, Wille PT, Raines EW: Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest 2006, 116:59-69 (Pubitemid 43121791)
20. Ordovas JM, Osgood D: Preparative isolation of plasma lipoproteins using fast protein liquid chromatography (FPLC). Methods Mol Biol 1998, 110:105-111
21. Montecino-Rodriguez EM, Loor F: Haematopoietic cell transfers between C57BL/6 mice differing at the lpr or gld locus. Immunology 1991, 74:127-131
22. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R: ApoEdeficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994, 14:133-140
23. VanderLaan PA, Reardon CA, Getz GS: Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol 2004, 24:12-22 (Pubitemid 38082406)
24. Rosenfeld ME, Polinsky P, Virmani R, Kauser K, Rubanyi G, Schwartz SM: Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol 2000, 20:2587-2592
25. Ma Z, Choudhury A, Kang SA, Monestier M, Cohen PL, Eisenberg RA: Accelerated atherosclerosis in ApoE deficient lupus mouse models. Clin Immunol 2008, 127:168-175
26. Gautier EL, Huby T, Ouzilleau B, Doucet C, Saint-Charles F, Gremy G, Chapman MJ, Lesnik P: Enhanced immune system activation and arterial inflammation accelerates atherosclerosis in lupus-prone mice. Arterioscler Thromb Vasc Biol 2007, 27:1625-1631 (Pubitemid 46986119)
27. Aprahamian T, Rifkin I, Bonegio R, Hugel B, Freyssinet JM, Sato K, Castellot JJ Jr, Walsh K: Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J Exp Med 2004, 199:1121-1131 (Pubitemid 38619908)
28. Kobayashi S, Hirano T, Kakinuma M, Uede T: Transcriptional repression and differential splicing of Fas mRNA by early transposon (ETn) insertion in autoimmune lpr mice. Biochem Biophys Res Commun 1993, 191:617-624 (Pubitemid 23222680)
29. Mariani SM, Matiba B, Armandola EA, Krammer PH: The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur J Immunol 1994, 24:3119-3123
30. Lynch DH, Watson ML, Alderson MR, Baum PR, Miller RE, Tough T, Gibson M, Davis-Smith T, Smith CA, Hunter K, Bhat D, Din W, Goodwin RG, Seldin MF: The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1994, 1:131-136
31. Zhou X, Paulsson G, Stemme S, Hansson GK: Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest 1998, 101:1717-1725 (Pubitemid 28198502)
32. Wahlsten JL, Gitchell HL, Chan CC, Wiggert B, Caspi RR: Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis. J Immunol 2000, 165:5480-5486
33. Matute-Bello G, Lee JS, Liles WC, Frevert CW, Mongovin S, Wong V, Ballman K, Sutlief S, Martin TR: Fas-mediated acute lung injury requires fas expression on nonmyeloid cells of the lung. J Immunol 2005, 175:4069-4075 (Pubitemid 41292070)
34. Boisvert WA, Rose DM, Johnson KA, Fuentes ME, Lira SA, Curtiss LK, Terkeltaub RA: Up-regulated expression of the CXCR2 ligand KC/ GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am J Pathol 2006, 168: 1385-1395
35. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ: Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998, 2:275-281 (Pubitemid 128373654)
36. Aiello RJ, Bourassa PA, Lindsey S, Weng W, Natoli E, Rollins BJ, Milos PM: Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 1999, 19:1518-1525 (Pubitemid 29263023)
37. Davenport P, Tipping PG: The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2003, 163:1117-1125 (Pubitemid 37040147)
38. Schieffer B, Selle T, Hilfiker A, Hilfiker-Kleiner D, Grote K, Tietge UJ, Trautwein C, Luchtefeld M, Schmittkamp C, Heeneman S, Daemen MJ, Drexler H: Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation 2004, 110: 3493-3500 (Pubitemid 39602229)
39. Madan M, Bishayi B, Hoge M, Amar S: Atheroprotective role of interleukin-in diet- and/or pathogen-associated atherosclerosis using an ApoE heterozygote murine model [Erratum appeared in Atherosclerosis 2008, 200:448-450]. Atherosclerosis 2008, 197:504-514 (Pubitemid 351417861)
40. Caligiuri G, Rudling M, Ollivier V, Jacob MP, Michel JB, Hansson GK, Nicoletti A: Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med 2003, 9:10-17 (Pubitemid 36667687)
41. Ahn JH, Park SM, Cho HS, Lee MS, Yoon JB, Vilcek J, Lee TH: Non-apoptotic signaling pathways activated by soluble Fas ligand in serum-starved human fibroblasts. Mitogen-activated protein kinases and NF-kappaB-dependent gene expression. J Biol Chem 2001, 276:47100-47106
42. O'Reilly LA, Tai L, Lee L, Kruse EA, Grabow S, Fairlie WD, Haynes NM, Tarlinton DM, Zhang JG, Belz GT, Smyth MJ, Bouillet P, Robb L, Strasser A: Membrane-bound Fas ligand only is essential for Fasinduced apoptosis. Nature 2009, 461:659-663